Endologix (ELGX) PT Lowered to $3.75 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- Broadcom shares climb as AI chip financing deal supports rally
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Endologix (ELGX) PT Lowered to $4 at BMO Capital
August 13, 2018 8:26 AM EDTBMO Capital analyst Joanne Wuensch lowered the price target on Endologix (NASDAQ: ELGX) to $4.00 (from $6.50) while maintaining a Market Perform rating.
... MorePiper Jaffray Downgrades Endologix (ELGX) to Neutral
August 10, 2018 5:11 AM EDTPiper Jaffray downgraded Endologix (NASDAQ: ELGX) from Overweight to Neutral with a price target of $4.75 (from $7.00).
Analyst Matt O''Brien comments "This afternoon, Endologix reported Q2 results that were a little light of our estimates. The big news from the release and conference call is... More
Endologix (ELGX) Posts Q2 Loss of $0.28/Share; Lowers Outlook
August 9, 2018 4:43 PM EDTEndologix (NASDAQ: ELGX) reported Q2 EPS of ($0.28), $0.13 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $44.7 million versus the consensus estimate of $44.45 million.
GUIDANCE:
Endologix sees FY2018 revenue of $145-155 million, versus prior of $170-$180... More



